Investor Relations

2018 Press Releases

Webcast ImageWebcast
Q1 2018 ConforMIS, Inc. Earnings Conference Call (Live)
05/02/18 at 4:30 p.m. ET
Q1 2018 ConforMIS, Inc. Earnings Conference Call
Wednesday, May 2, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
04/12/18
Conformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018
BILLERICA, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 2, 2018, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2018.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 1695267. The conference call will be hosted by Mark Augusti, President and Chief Executive Officer, and Paul Weiner,... 

Read more »
03/07/18
Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients BILLERICA, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient’s unique anatomy, today announced new data showing that patients treated with the Conformis iTotal CR knee implant experienced a cumulative revision rate of 0.5... 

Read more »
03/01/18
Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
Rating highlights positive three-year survivorship following total knee arthroplasty BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient's unique anatomy, today announced that the Orthopaedic Data Evaluation Panel in the United Kingdom (ODEP) (http://www.odep.org.uk/ODEPExplained.aspx) awarded the Conformis iTotal CR knee replacemen... 

Read more »
02/07/18
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
BILLERICA, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2017. Q4 Summary Total revenue of $20.8 million, down 4% year-over-year on a reported basis and 5% on a... 

Read more »
01/25/18
ConforMIS Announces Pricing of Public Offering of Common Stock
BILLERICA, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ConforMIS,  Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, today announced the pricing of an underwritten public offering of 13,333,333 shares of its common stock at a public offering price of $1.50 per share, before underwriting discounts, raising $20 milli... 

Read more »
01/24/18
ConforMIS Announces Proposed Public Offering of Common Stock
BILLERICA, Mass., Jan. 24, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, today announced that it has commenced an underwritten public offering of its common stock. ConforMIS also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen perc... 

Read more »
01/08/18
ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
ConforMIS to Host Fourth Quarter and the Year Ended 2017 Financial Results Conference Call and Webcast on February 7, 2018 BILLERICA, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today preliminary, unaudited, revenue results for the fourth quart... 

Read more »
01/04/18
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, today announced the publication of a prospective study in The Journal of Knee Surgery, a peer-reviewed orthopedic journal, on December 14, 2017. The study investigated the ability of the iTotal CR Knee Replacement System restoring coronal plane mechanical axis alignment in a patient... 

Read more »